| Authors: |
Eapen R; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom., Okoye C; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom., Stubbs C; AstraZeneca, Cambridge, United Kingdom., Schimpl M; AstraZeneca, Cambridge, United Kingdom., Tischer T; MRC Laboratory of Molecular Biology, Cambridge, United Kingdom., Fisher EJ; AstraZeneca, Cambridge, United Kingdom., Zacharopoulou M; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom., Ferrer F; p53 Laboratory, Singapore, Singapore., Barford D; MRC Laboratory of Molecular Biology, Cambridge, United Kingdom., Spring DR; Yusuf Hamid Department of Chemistry, University of Cambridge, Cambridge, United Kingdom., Lindon C; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom., Phillips C; AstraZeneca, Cambridge, United Kingdom., Itzhaki LS; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom. |